Bicara Therapeutics (BCAX) Q4 2024 Earnings

Nov 12Confirmed
Q4 2024
-1.6
-1.2
-0.81
-0.41

Details

Expected EPS
-0.41
Actual EPS
-1.6
Surprise EPS
-1.19
Surprise Percent
-290.24%

Description

⁨Bicara Therapeutics⁩ (⁦BCAX⁩) has reported earnings of ⁦-1.6⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts